Transparency in the reporting of nursing research by Smith, |G.D. et al.
Transparency in the reporting of nursing research 
 
Smith G, Gelling L, Haigh C, Barnason S, Allan H, Penny K & Jackson D 
 
Recently, the integrity of reporting nursing research studies has been brought 
into question, with claims that less than half of clinical trials published in leading 
nursing journals are officially registered (Gray et al 2017). These authors suggest 
that because of this, the quality of published outcome analysis definitions and 
trial registrations in nursing journals is often sub- optimal. 
 
At the Journal of Clinical Nursing we believe that all nursing research should be 
conducted with integrity, and in compliance with internationally recognized and 
accepted reporting guidelines. The end consumer of published nursing research 
will benefit by reading papers that clearly and transparently state how the study 
was conducted. Whether the reader is a clinical nurse who is seeking evidence to 
provide better care for patients or a student nurse trying to enhance their 
understanding of a specific topic, the benefits of responsible research reporting 
are considerable. Good quality nursing research which is reported responsibly 
has the potential to improve patient care, influence policy and to advance the 
nursing scientific knowledge base. 
 
More than just endorsing reporting guidelines for our authors, we feel that is 
timely and important for our reviewers to be aware and comply with them. In 
summary, we believe that greater attention to proper trial registration and 
outcome analysis definition in published reports is imperative to, helping to 
ensure that good quality nursing care can be delivered from a valid and reliable 
evidence base. 
 
 
Researchers often appeal to potential subjects’ willingness to contribute to 
advancing science through study participation.  Clinical trial registration is a 
means to assure and meet the ethical obligation to respect subjects’ participation 
in research studies. (krleza-Jeric et al., 2005) Furthermore, accurately reported 
information from well-designed and rigorously conducted studies is necessary for 
readers to have confidence in the findings of research (Altman & Simera 
2010). Deficiencies in trial design and inaccurate reporting, can lead potentially 
to the publication of biased estimates of treatment effects, placing limitations on 
the research (Altman 2002). However, well-designed studies are not sufficient in 
themselves to ensure transparency in empirical nursing research, not publishing 
negative or detrimental studies is a limitation to inform the state of the science 
and is also a form of scientific misconduct (Al-Marzouki et al., 2005). It is the 
presentation of evidence that is of upmost importance in a published scientific 
article. 
We aim to publish the highest quality research papers that have relevance to 
several groups including; researchers, educators, policy-makers, clinicians and 
patients. We have long supported the use of reporting guidelines to ensure that 
our publications, including systematic reviews, have transparency and can be 
judged appropriately by our readers. 
 
 
In this editorial, we outline the rationale for adopting the range of reporting 
guidelines that we endorse at the Journal of Clinical Nursing and highlight the 
necessity of trial registration. Although most attention in the biomedical 
literature has been given to the remit of reporting guidelines in quantitative 
research, reporting guidelines have a role in all types of research. This editorial 
will emphasise reporting guidelines and trial registration for quantitative 
research methods. Attention will be given to the place of reporting guidelines in 
qualitative studies in a future (subsequent) editorial. 
 
To have confidence that a study’s findings accurately reflect intervention 
effectiveness depends on proper trial conduct and the accuracy and 
completeness of published study reports (Chalmers & Glasziou 2009). Poor 
reporting practices may seriously distort the published evidence, compromising 
its worth and reliability. Indeed, inadequate reporting may render a study’s 
findings redundant (Jull & Aye 2015). 
 
Commonly reported issues in poor quality research design can include failure to 
disclose a primary analysis; the non-reporting or delayed reporting of complete 
studies; omission of critical information in the description of study methods; 
insufficient description of interventions; presenting facts in a misleading way; 
and omissions from or misinterpretation of results in abstracts. All of these 
deficiencies have potentially serious consequences for clinical practice, research, 
education, policymaking and, ultimately, the care and safety of patients (Simera 
et al 2008). 
 
As a response to sub-optimal quality of reporting of biomedical research, 
including nursing research, guidelines for several different types of study design 
have been developed by EQUATOR© to ensure accurate reporting and 
transparency for reviewers, readers from the scientific community and general 
public. 
 
 
 
What is EQUATOR©? 
 
 
EQUATOR© research reporting guidelines provide specific recommendations for 
the reporting of different types of research. Experts in study design, 
epidemiology, biostatistics, and research methodology have produced several 
EQUATOR© guidelines (Altman & Moher 2014). Many of these reporting 
guidelines include detailed checklists of items that can be included within a 
manuscript as part of the submission process, in some guidelines a flow diagram 
displaying the progress of study participants is incorporated. 
The CONSORT statement flow diagram provides a simple outline of how a study 
population was recruited and handled during the course of a study. Use of 
reporting guidelines can augment the transparency in the reporting of scientific 
research, making possibly easier for readers to assess and evaluate the quality of 
the study. Failure to follow the acknowledged international guidelines makes it 
difficult for readers to fully assess a study’s rigour and transparency (Simera et 
al 2008). Presently, any study that fails to adhere to these reporting guidelines 
may be considered to have a risk of bias even if the study has been conducted 
rigorously. 
 
 
Advantages of EQUATOR Compliance 
 
 
It may be reasonable for authors to ask how EQUATOR guidelines can help the 
overall quality of their published research.  From the perspective of Journal of 
Clinical Nursing, it is clear that the use of reporting guidelines can benefit 
academic nursing at several levels enhancing the profession as outlined in this 
editorial, enhancing our research integrity and transparency. 
For potential journal authors, compliance with the appropriate EQUATOR 
reporting guidelines provides editorial offices with an indicator of the 
thoroughness of a submission. However, there are additional advantages that 
compliance provides to manuscript submission (Johansen & Thomsen 2016). 
Authors should not view reporting guidelines as an imposition, but as a handy 
author tool to enhance the quality of submissions (Altman & Simera 2010). The 
work of reviewers and editors when reviewing papers is made much easier 
when a consistent and readily recognizable submission structure is presented, 
potentially speeding up the decision time. 
 
Within the Journal of Clinical Nursing author guidelines we actively encourage 
our authors to state limitations in their study. It is clear that no research study is 
absolutely perfect and increasing transparency in manuscripts may reveal 
additional limitations within a study. This need not prevent publication as editors 
and reviewers will be able to make an informed judgement about limitations, if 
presented in a transparent fashion. 
 
At present, the Journal of Clinical Nursing endorses the following quantitative 
reporting guidelines: 
 
 
Randomized (and quasi randomized) controlled trials: CONSORT –consolidated 
standards of reporting trials (Schultz et al 2010) 
Observational, cohort, case control and cross-sectional studies: STROBE- 
strengthening the reporting of observational studies in epidemiology (von Elm et 
al. 2008). 
 
 
Systematic review of controlled trials: PRISMA- preferred reporting items for 
systematic reviews and meta-analyses (Moher et al). 
 
 
It is fully anticipated that in time more and more reporting guidelines will be 
endorsed by biomedical academic journals including nursing journals. Indeed, 
other quantitative reporting guidelines are emerging all the time, including 
SAMPL (Basic statistical reporting for articles published in biomedical journals: 
the "Statistical Analyses and Methods in the Published Literature" or the SAMPL 
Guidelines), however the same level of evidence as CONSORT or PRISMA does 
not support these (Lang & Altman 2015). 
 
 
Trial registration 
Since 2005, the International Committee of Medical Journal Editors (ICMJE) has 
required trial registration in public trial registries prior to patient enrolment for 
studies to be considered for publication (ICMJE 2016). Trial registration policies 
consistent with the ICMJE policy have been widely adopted across many 
biomedical journals, including Journal of Clinical Nursing. ICMJE guidelines 
require a priori specification of the primary and secondary outcomes in the trial 
registration (De Angelis et al 2004). 
 
To date, many nurse researchers may not be fully aware of the need for 
prospective trial registration on a WHO-compliant register or the ethical 
considerations of non-registration. The International Clinical Trials Registry 
Platform (ICTRP) is a global initiative that aims to make information about all 
clinical trials involving human beings publicly available (World Health 
Organization 2012). Registration is not a time-consuming or costly procedure. 
Through adherence to the CONSORT statement, we effectively ensure that 
registration is required for all clinical trials. As highlighted by Gray et al (2017), 
there remains a need to develop a greater awareness among nurse authors and 
reviewers of the importance of trial registration. 
 
Poor study reporting cannot be as an isolated issue that can be fixed be targeting 
one of the parties involved in the publishing process, be it authors, editors or 
reviewers. A well-coordinated approach between ethics, governance, research 
and publishing communities is most likely to influence the quality of future 
research publications (Hale & Griffiths 2015). In our view, all nursing journal 
editors need to be explicit about the need for authors to register trials when 
appropriate. 
Our solution to inadequate reporting may lie with a more robust editorial 
position on adherence to reporting guidelines (the CONSORT Statement) and 
trial registration, as well as ensuring reviewers and all involved in the editorial 
process understand and adhere to the necessity of adequate reporting. ICMJE 
have suggested that if the author is uncertain whether their study meets the 
definition for a clinical trial that they should err on the side of registration 
(ICJME, 2016). 
 
 
Use of Consolidated Standards of Reporting Trials (CONSORT) for RCTs along 
with prospective registration of all clinical trials can assist in assuring that 
appropriate information needed is present, potentially speeding up the peer 
review process. Endorsment of trial registration and CONSORT requirements by 
journal editorial teams should enhance the peer review process by providing 
authors and reviewers with the tools to ensure that they can effectively 
implement these requirements (Simera et al 2010). 
 
Improving consistency in reporting requires the nursing publishing community 
to promote adherence as a collective; tonot publish trials that are not adequately 
reported and registered on a WHO compliant trials register where appropriate. 
This would be a good starting point ls to enhance research integrity, and would 
address concerns raised by Gray et al (2017). 
 
Descriptions of intervention and control groups as reported in a paper reporting 
an RCT should identically match information provided on the trial registration 
site. In addition, primary outcomes should be analyzed as indicated. At the 
Journal of Clinical Nursing, questions used to obtain this information are part of 
the online manuscript submission process. 
 
Journal editors and reviewers have a responsibility to assure that study 
manuscripts are consistent with what has been registered and should not 
preferentially publish trials with positive findings at the expense of those with 
negative results (Wager & Williams 2013). Hence, nursing journal editors, 
publishers, funding agencies, ethics and governance committees, and 
professional and academic associations can all play a role in advocating for the 
implementation of trial registration. Beyond the Journal of Clinical Nursing, the 
scientific community, including researchers, other journals, academic 
institutions, and funders, would serve the public better if more attention were 
paid to the accurate and transparent reporting of clinical trials of nursing 
research. 
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